Drug Information

Drug General Information
Drug ID
D03ZUM
Former ID
DNC014635
Drug Name
Tert-butyloxy carbonyl-D-Phe-pro-Arg-H
Drug Type
Small molecular drug
Indication Discovery agent Investigative [533588]
Formula
C25H38N6O5
Canonical SMILES
CC(C)(C)OC(=O)NC(CC1=CC=CC=C1)C(=O)N2CCCC2C(=O)NC(CCCN=<br />C(N)N)C=O
InChI
1S/C25H38N6O5/c1-25(2,3)36-24(35)30-19(15-17-9-5-4-6-10-17)22(34)31-14-8-12-20(31)21(33)29-18(16-32)11-7-13-28-23(26)27/h4-6,9-10,16,18-20H,7-8,11-15H2,1-3H3,(H,29,33)(H,30,35)(H4,26,27,28)/t18-,19+,20-/m0/s1
InChIKey
JDXUSWQJCGTBLN-ZCNNSNEGSA-N
PubChem Compound ID
6917805
Target and Pathway
Target(s) Trypsin Target Info Inhibitor [533588]
KEGG Pathway Neuroactive ligand-receptor interaction
Pancreatic secretion
Protein digestion and absorption
Influenza A
Reactome Activation of Matrix Metalloproteinases
Cobalamin (Cbl, vitamin B12) transport and metabolism
WikiPathways Activation of Matrix Metalloproteinases
References
Ref 533588J Med Chem. 1995 Oct 27;38(22):4446-53.Structure-activity study of tripeptide thrombin inhibitors using alpha-alkyl amino acids and other conformationally constrained amino acid substitutions.
Ref 533588J Med Chem. 1995 Oct 27;38(22):4446-53.Structure-activity study of tripeptide thrombin inhibitors using alpha-alkyl amino acids and other conformationally constrained amino acid substitutions.